查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1592903

生育治疗市场：按产品类型、程序、患者类型、最终用户 - 2025-2030 年全球预测

Infertility Treatment Market by Product (Accessories, Equipment, Media & Consumables), Procedure (Artificial Insemination, Assisted Reproductive Technology, Fertility Surgeries), Patient type, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，生育治疗市场价值为53.5亿美元，预计到2024年将达到59.3亿美元，复合年增长率为11.26%，预计到2030年将达到113亿美元。

不孕症治疗市场包括各种旨在帮助无法自然受孕的个人和夫妇的治疗方法。这些治疗包括体外受精 (IVF) 等辅助生殖技术 (ART)、生育药物、手术和其他干预措施。由于生活方式因素、健康状况、延迟生育等原因，越来越多的人面临不孕不育的挑战，因此需要不孕症治疗。最终用途范围主要包括生育诊所、医院、手术中心以及越来越多透过专业生育中心提供的服务。该市场的主要成长要素包括辅助生殖技术的技术进步、不孕症治疗资金和保险覆盖范围的增加以及人们对不孕症治疗的认识不断提高。然而，某些限制和挑战仍然存在，例如与治疗相关的高成本、文化和社会偏见以及因地区而异的监管情况。

主要市场统计
基准年[2023] 53.5亿美元
预测年份 [2024] 59.3亿美元
预测年份 [2030] 113亿美元
复合年增长率（%） 11.26%

最新的潜在治疗机会在于开发更具成本效益和侵入性较小的治疗方案，这主要是由诊断工具和个人化医疗方法的创新所推动的。此外，鑑于可支配收入的增加和人口结构的变化，新兴市场提供了巨大的商机。为相关人员提供的研究建议包括投资研究以提高治疗成功率并减少副作用，与医疗保健提供者合作以提高可及性，以及非人性化不孕症问题的例子包括客户教育措施。有关 ART 的严格监管要求和道德问题等限制可能会减缓市场成长。儘管存在这些挑战，该市场仍存在创新领域，特别是在基因筛检和胚胎选择技术方面，这些技术可以提高成功率并完善个人化治疗。市场正在向综合护理方法发展，将医疗治疗与咨询和营养指导等支持服务相结合，提供符合消费者偏好的整体解决方案。

市场动态：揭示快速发展的生育市场的关键市场洞察

供需的动态交互作用正在改变不孕症治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球基础建设计划不断涌现
    • 由于可靠性和耐用性，对导线管的潜在需求
    • 智慧电网网路快速扩张
  • 市场限制因素
    • 对原物料电压的担忧
  • 市场机会
    • 数位化导致用电量快速增加
    • 电网基础设施的持续维修和维修活动
  • 市场挑战
    • 安装过程困难，布线缺陷难以发现

波特五力：驾驭生育市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生育治疗市场的外在影响

外部宏观环境因素在塑造不孕症治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解不孕症治疗市场的竞争状况

生育治疗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵生育治疗市场供应商的绩效评估

FPNV定位矩阵是评估生育市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了生育治疗市场的成功之路

对于希望加强在全球市场的影响力的公司来说，生育治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球基础建设计划不断增加
      • 由于可靠性和耐用性，对电气导管的潜在需求
      • 智慧电网网路快速扩张
    • 抑制因素
      • 原物料价格波动的担忧
    • 机会
      • 数位化导致用电量增加
      • 电网基础设施的持续维修和改造活动
    • 任务
      • 安装过程困难，接线缺陷难以发现
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 生育治疗市场：副产品

  • 配件
  • 装置
    • 冷冻系统
    • 气体分析仪
    • 影像系统
    • 培养箱
    • 雷射系统
    • 显微作业系统
    • 显微镜
    • 抽卵子泵
    • 精子分析系统
    • 精子分离装置
  • 媒体和用品

第七章 不孕症市场的程序

  • 人工授精
    • 子宫颈内人工授精
    • 输卵管内授精
    • 子宫内人工授精
  • 辅助生殖技术
    • 体外受精
      • 配子捐赠
      • 形态选择精子的胞浆内注射
    • 卵细胞质内单一精虫显微注射术
    • 代孕
  • 不孕不育治疗手术
    • 子宫镜检查
    • 腹腔镜检查
    • 开放性手术
    • 显微外科重组
      • 输精管睪丸切开术
      • 血管造口术
    • 子宫肌瘤切除术
    • 输卵管结扎松解术
    • 静脉曲张切除术

第八章按患者类型分類的生育治疗市场

  • 女性不孕症治疗
  • 男性不孕症治疗

第九章 生育治疗市场：依最终使用者分类

  • 冷冻库
  • 不孕不孕治疗中心
  • 医院和外科诊所
  • 调查机构

第十章美洲生育治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太生育治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的生育治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • ABB Limited
  • Aliaxis Group SA
  • ANAMET Electrical, Inc.
  • Astral PolyTechnik Limited
  • Atkore International Holdings Incorporated
  • Cantex, Inc.
  • China Lesso Group Holdings Ltd.
  • Dura-line Corporation
  • Electri-Flex Company
  • Hellermanntyton group plc
  • Hubbell Incorporated
  • Legrand SA
  • Nan Ya Plastics Corp.
  • National pipe & plastics, Inc.
  • Orbia Advance Corporation
  • Schneider Electric SE
  • Sekisui Chemical Co., Ltd.
  • Thomas & Betts Corporation
  • Wienerberger AG
  • Zekelman Industries Inc.
Product Code: MRR-3E32260F8122

The Infertility Treatment Market was valued at USD 5.35 billion in 2023, expected to reach USD 5.93 billion in 2024, and is projected to grow at a CAGR of 11.26%, to USD 11.30 billion by 2030.

The infertility treatment market encompasses a range of therapeutic approaches aimed at aiding individuals and couples unable to conceive naturally. These treatments include assisted reproductive technologies (ART) like in vitro fertilization (IVF), fertility drugs, surgeries, and other interventions. The necessity for infertility treatments arises from the growing number of individuals facing fertility challenges due to lifestyle factors, health conditions, and delayed childbearing. The end-use scope primarily includes fertility clinics, hospitals, and surgical centers, with an increasing number of services also being offered through specialized fertility centers. Key growth factors for this market include technological advancements in ART, increased funding and insurance coverage for infertility treatments, and growing awareness regarding fertility preservation. However, certain limitations and challenges remain, such as the high costs associated with treatments, cultural and social stigmas, and varying regulatory landscapes across regions.

KEY MARKET STATISTICS
Base Year [2023] USD 5.35 billion
Estimated Year [2024] USD 5.93 billion
Forecast Year [2030] USD 11.30 billion
CAGR (%) 11.26%

Latest potential opportunities lie in the development of more cost-effective and minimally invasive treatment options, largely driven by innovation in diagnostic tools and personalized medicine approaches. Additionally, emerging markets present significant opportunities, given the increasing disposable income and changing demographics. Recommendations for stakeholders include investing in research to improve success rates of treatments and reduce side-effects, enhancing accessibility through partnerships with healthcare providers, and engaging in customer education initiatives to destigmatize infertility issues. Limitations such as stringent regulatory requirements and ethical concerns related to ART can slow down market growth. Despite these challenges, the market offers areas of innovation, particularly in genetic screening and embryo selection technologies, which can increase success rates and refine personalization in treatments. The market is evolving towards an integrated care approach, combining medical treatments with supportive services like counseling and nutritional guidance, offering a holistic solution that is gaining favor in consumer preferences.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infertility Treatment Market

The Infertility Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of infrastructure projects all over the world
    • Potential demand for electrical conduit owing to reliability and durability
    • Rapid extension of smart grid networks
  • Market Restraints
    • Concern associated with raw material voltality
  • Market Opportunities
    • Proliferation of electricity usage attributed to digitalization
    • Ongoing refurbishment and retrofit activities in grid infrastructure
  • Market Challenges
    • Difficulty in installation process coupled with hard to find defects in wiring

Porter's Five Forces: A Strategic Tool for Navigating the Infertility Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infertility Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infertility Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infertility Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infertility Treatment Market

A detailed market share analysis in the Infertility Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infertility Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infertility Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infertility Treatment Market

A strategic analysis of the Infertility Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infertility Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Limited, Aliaxis Group S.A., ANAMET Electrical, Inc., Astral PolyTechnik Limited, Atkore International Holdings Incorporated, Cantex, Inc., China Lesso Group Holdings Ltd., Dura-line Corporation, Electri-Flex Company, Hellermanntyton group plc, Hubbell Incorporated, Legrand S.A., Nan Ya Plastics Corp., National pipe & plastics, Inc., Orbia Advance Corporation, Schneider Electric SE, Sekisui Chemical Co., Ltd., Thomas & Betts Corporation, Wienerberger AG, and Zekelman Industries Inc..

Market Segmentation & Coverage

This research report categorizes the Infertility Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Equipment, and Media & Consumables. The Equipment is further studied across Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices.
  • Based on Procedure, market is studied across Artificial Insemination, Assisted Reproductive Technology, and Fertility Surgeries. The Artificial Insemination is further studied across Intracervical Insemination, Intratubal Insemination, and Intrauterine Insemination. The Assisted Reproductive Technology is further studied across In Vitro Fertilization, Intracytoplasmic Sperm Injection, and Surrogacy. The In Vitro Fertilization is further studied across Gamete Donation and Intracytoplasmic Morphologically Selected Sperm Injection. The Fertility Surgeries is further studied across Hysteroscopy, Laparoscopy, Laparotomy, Microsurgical Reconstruction, Myomectomy, Tubal Ligation Reversal, and Varicocelectomy. The Microsurgical Reconstruction is further studied across Vasoepididymostomy and Vasovasostomy.
  • Based on Patient type, market is studied across Female Infertility Treatment and Male Infertility Treatment.
  • Based on End User, market is studied across Cryobanks, Fertility Centers, Hospitals & Surgical Clinics, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of infrastructure projects all over the world
      • 5.1.1.2. Potential demand for electrical conduit owing to reliability and durability
      • 5.1.1.3. Rapid extension of smart grid networks
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with raw material voltality
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation of electricity usage attributed to digitalization
      • 5.1.3.2. Ongoing refurbishment and retrofit activities in grid infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Difficulty in installation process coupled with hard to find defects in wiring
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infertility Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Equipment
    • 6.3.1. Cryosystems
    • 6.3.2. Gas Analyzers
    • 6.3.3. Imaging Systems
    • 6.3.4. Incubators
    • 6.3.5. Laser Systems
    • 6.3.6. Micromanipulator Systems
    • 6.3.7. Microscopes
    • 6.3.8. Ovum Aspiration Pumps
    • 6.3.9. Sperm Analyzer Systems
    • 6.3.10. Sperm Separation Devices
  • 6.4. Media & Consumables

7. Infertility Treatment Market, by Procedure

  • 7.1. Introduction
  • 7.2. Artificial Insemination
    • 7.2.1. Intracervical Insemination
    • 7.2.2. Intratubal Insemination
    • 7.2.3. Intrauterine Insemination
  • 7.3. Assisted Reproductive Technology
    • 7.3.1. In Vitro Fertilization
      • 7.3.1.1. Gamete Donation
      • 7.3.1.2. Intracytoplasmic Morphologically Selected Sperm Injection
    • 7.3.2. Intracytoplasmic Sperm Injection
    • 7.3.3. Surrogacy
  • 7.4. Fertility Surgeries
    • 7.4.1. Hysteroscopy
    • 7.4.2. Laparoscopy
    • 7.4.3. Laparotomy
    • 7.4.4. Microsurgical Reconstruction
      • 7.4.4.1. Vasoepididymostomy
      • 7.4.4.2. Vasovasostomy
    • 7.4.5. Myomectomy
    • 7.4.6. Tubal Ligation Reversal
    • 7.4.7. Varicocelectomy

8. Infertility Treatment Market, by Patient type

  • 8.1. Introduction
  • 8.2. Female Infertility Treatment
  • 8.3. Male Infertility Treatment

9. Infertility Treatment Market, by End User

  • 9.1. Introduction
  • 9.2. Cryobanks
  • 9.3. Fertility Centers
  • 9.4. Hospitals & Surgical Clinics
  • 9.5. Research Institutes

10. Americas Infertility Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Infertility Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Infertility Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABB Limited
  • 2. Aliaxis Group S.A.
  • 3. ANAMET Electrical, Inc.
  • 4. Astral PolyTechnik Limited
  • 5. Atkore International Holdings Incorporated
  • 6. Cantex, Inc.
  • 7. China Lesso Group Holdings Ltd.
  • 8. Dura-line Corporation
  • 9. Electri-Flex Company
  • 10. Hellermanntyton group plc
  • 11. Hubbell Incorporated
  • 12. Legrand S.A.
  • 13. Nan Ya Plastics Corp.
  • 14. National pipe & plastics, Inc.
  • 15. Orbia Advance Corporation
  • 16. Schneider Electric SE
  • 17. Sekisui Chemical Co., Ltd.
  • 18. Thomas & Betts Corporation
  • 19. Wienerberger AG
  • 20. Zekelman Industries Inc.

LIST OF FIGURES

  • FIGURE 1. INFERTILITY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. INFERTILITY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. INFERTILITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFERTILITY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAMETE DONATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VASOEPIDIDYMOSTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VASOVASOSTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TUBAL LIGATION REVERSAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS & SURGICAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 202. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 221. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 222. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 223. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 232. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 233. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 235. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 241. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 242. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 243. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 245. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 246. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 260. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 262. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 263. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 264. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 266. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 267. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 268. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 272. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 273. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 274. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 276. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 277. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 278. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 282. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 283. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 284. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 286. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 287. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 288. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 292. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 293. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 294. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 296. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 297. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 298. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 302. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 303. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 304. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 306. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 307. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 308. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 312. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 313. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 314. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 316. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 317. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 318. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 321. ITALY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 322. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 323. ITALY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATIO